Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Treatment With Tranexamic Acid in Melanoma; Prognostic and Treatment-related Impact of the Plasminogen-plasmin Pathway

NCT05899465 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05899465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Treatment With Tranexamic Acid in Melanoma; Prognostic and Treatment-related Impact of the Plasminogen-plasmin Pathway
Lead sponsor
University of Aarhus
Phase
Phase 3
Overall status
Recruiting
Start date
August 25, 2023
Completion date
September 1, 2028
Enrollment
1,204 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma